Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter

Nucleic Acids Research

Volumn 29, Issue 19, 2001, Pages 3919-3927

  Ogbourne, Steven M ^a   Antalis, Toni M ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BINDING PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATOR INHIBITOR 2 UPSTREAM SILENCER ELEMENT 1; SERINE PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; CROSS LINKING; DEGRADATION; EXTRACELLULAR MATRIX; FIBRINOLYSIS; GENE EXPRESSION REGULATION; GENE INSERTION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; KERATINOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; SILENCER GENE; ULTRAVIOLET RADIATION; VIRUS;

EID: 0035477917     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.19.3919     Document Type: Article

References (39)

1. The ovalbumin family of serpin proteins
2. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha induced apoptosis. Evidence for an alternate biological function
3. MENT, a heterochromatin protein that mediates higher order chromatin folding, is a new serpin family member
4. Maspin. A tumor suppressing serpin
5. Protease inhibitor 10 inhibits tumor necrosis factor alpha-induced cell death. Evidence for the formation of intracellular high M(r) protease inhibitor 10-containing complexes
6. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells
7. Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor
8. Biological and clinical aspects of plasminogen activator inhibitor type 2
9. Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice
10. The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming
11. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4
12. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2
13. Localization of plasminogen activator inhibitor type 2 (PAI-2) in hair and nail: Implications for terminal differentiation
14. Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes
15. Peripheral blood monocyte synthesis of plasminogen activator inhibitor 2 in response to native and modified LDL
16. Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2
17. Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter
18. Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression
19. Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-kappaB-like transcriptional regulatory motif
20. Chromosomal organization and localization of the human urokinase inhibitor gene: Perfect structural conservation with ovalbumin
21. Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin
22. Transcriptional control and the role of silencers in transcriptional regulation in eukaryotes
23. Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: Localization of an upstream transcriptional silencer
24. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line
25. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes
26. Cross-sensitivity of methylating agents, hydroxyurea and methotrexate in human tumor cells of the Mer-phenotype
27. Isolation of intact nuclei from hematopoietic cell types
28. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
29. Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells
30. Transcriptional repression by v-Ski and c-Ski mediated by a specific DNA binding site
31. Identification and characterization of a novel transcriptional silencer in the human collagen type IV gene COL4A2
32. Identification of a transcriptional silencer in the protein-coding region of the mouse major inducible Hsp70 gene
33. Knockout of REST/NRSF shows that the protein is a potent repressor of neuronally expressed genes in non-neural tissues
34. An EMSA-based method for determining the molecular weight of a protein-DNA complex
35. Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements
36. Repression of the ovalbumin gene involves multiple negative elements including a ubiquitous transcriptional silencer
37. Gene gun-mediated in vivo analysis of tissue-specific repression of gene transcription driven by the chicken ovalbumin promoter in the liver and oviduct of laying hens
38. The molecular basis of the undulated/Pax-1 mutation
39. Human Smad3 and Smad4 are sequence-specific transcription activators